These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4068219)

  • 21. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
    Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
    Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of cefaclor for respiratory tract infections].
    Hiraga Y; Kikuchi K; Yamamoto A
    Jpn J Antibiot; 1984 Apr; 37(4):581-8. PubMed ID: 6471379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
    Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Hiraga Y; Omichi M; Sasaoka S
    Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
    Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
    Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies of cefotiam in otorhinolaryngologic infections].
    Satake K; Tanino T; Naito T; Osafune H; Komatsuzaki A
    Jpn J Antibiot; 1983 Oct; 36(10):2683-7. PubMed ID: 6325737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of S6472 and cefaclor on bacterial flora in adult human feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Jan; 39(1):177-246. PubMed ID: 3702058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of cefaclor in urinary tract infections (2)].
    Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
    Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
    Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
    Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of TMS-19-Q, a new macrolide antibiotic, in otorhinolaryngological infections].
    Baba S; Wada K; Hatano T; Murai K; Kinoshita H; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ueda R
    Jpn J Antibiot; 1985 Mar; 38(3):595-614. PubMed ID: 3897601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies on cefadroxil in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Suzuki K; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Yamamoto M; Komatsu Y; Koga M; Ohta M; Tanaka M; Takasaki Y; Nagai T
    Jpn J Antibiot; 1983 Jan; 36(1):93-102. PubMed ID: 6842830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Absorption and excretion studies of S6472 (sustained release preparations of cefaclor)].
    Tateno M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):834-48. PubMed ID: 4032715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefaclor--summary of clinical experience.
    Kammer RB; Short LJ
    Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
    Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
    Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutical experience of cefadroxil against acute infectious diseases in the otorhinolaryngological field (author's transl)].
    Nagaba M
    Jpn J Antibiot; 1980 Mar; 33(3):253-5. PubMed ID: 7401306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prolonged action preparation of cefaclor].
    Sakamoto T; Kawai S; Doi Y; Aita K; Sonoyama T; Nishimura K; Matsuda S; Ito M; Imagawa T; Yasuda M
    Jpn J Antibiot; 1985 Mar; 38(3):813-21. PubMed ID: 3897611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with cefadroxil in otorhinolaryngological infections].
    Iino Y; Kobayashi T; Kawamoto K
    Jpn J Antibiot; 1983 Sep; 36(9):2497-501. PubMed ID: 6655865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinical studies on cefadroxil dry syrup in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1981 Jan; 34(1):33-40. PubMed ID: 7241805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
    Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
    Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.